We are live on
!
Find out more
IAP
Indie Asset Partners Portfolio holdings
AUM
$104M
1-Year Est. Return
31.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+31.76%
3 Year Est. Return
+118.95%
5 Year Est. Return
+164.44%
10 Year Est. Return
–
AUM
$85.6M
AUM Growth
-$5.64M
(-6.2%)
Cap. Flow
-$4.64M
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
64.93%
Holding
93
New
8
Increased
6
Reduced
46
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$539K |
| 2 |
Eli Lilly
LLY
|
+$287K |
| 3 |
Target
TGT
|
+$212K |
| 4 |
Fastenal
FAST
|
+$202K |
| 5 |
Qualcomm
QCOM
|
+$197K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$1.08M |
| 2 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$552K |
| 3 |
Vanguard High Dividend Yield ETF
VYM
|
+$480K |
| 4 |
Amazon
AMZN
|
+$396K |
| 5 |
Zimmer Biomet
ZBH
|
+$339K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.55% |
| 2 | Miscellaneous | 22.04% |
| 3 | Technology | 9.98% |
| 4 | Consumer Discretionary | 3.37% |
| 5 | Industrials | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.01T
| $22.5M | 26.23% |
65,389
+851
| +1% | +$287K |
|
|
2
Royalty Pharma
RPRX
$26.3B
| $15.6M | 18.22% |
433,000
-29,000
| -6% | -$1.08M |
|
3
Apple
AAPL
$4.86T
| $5.88M | 6.87% |
35,663
-634
| -2% | -$93.5K |
|
4
Schwab US Dividend Equity ETF
SCHD
$112B
| $2.33M | 2.72% |
95,391
+6,159
| +7% | +$154K |
|
5
Vanguard Energy ETF
VDE
$11B
| $2.2M | 2.57% |
19,296
-231
| -1% | -$27.4K |
|
6
Microsoft
MSFT
$3.75T
| $1.66M | 1.94% |
5,763
| – | – |
|
7
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.93B
| $1.62M | 1.89% |
21,266
-2,450
| -10% | -$195K |
|
|
8
Amazon
AMZN
$2.73T
| $1.5M | 1.75% |
14,490
-4,095
| -22% | -$396K |
|
9
Meta Platforms (Facebook)
META
$1.7T
| $1.17M | 1.37% |
5,531
-30
| -0.5% | -$5.11K |
|
10
iShares US Transportation ETF
IYT
$2.12B
| $1.16M | 1.36% |
20,424
-3,360
| -14% | -$192K |
|
11
iShares 20+ Year Treasury Bond ETF
TLT
$46.6B
| $1.1M | 1.28% |
10,300
+1,000
| +11% | +$105K |
|
12
iShares MSCI Agriculture Producers ETF
VEGI
$172M
| $1.05M | 1.23% |
25,075
-1,500
| -6% | -$64.1K |
|
13
Alerian MLP ETF
AMLP
$13.5B
| $882K | 1.03% |
22,825
-1,000
| -4% | -$39.2K |
|
14
First Trust Capital Strength ETF
FTCS
$7.73B
| $860K | 1% |
11,785
-1,917
| -14% | -$141K |
|
15
McDonald's
MCD
$182B
| $842K | 0.98% |
3,012
-29
| -1% | -$7.77K |
|
16
Schwab US Large-Cap Growth ETF
SCHG
$62.5B
| $824K | 0.96% |
50,592
-200
| -0.4% | -$3.04K |
|
17
PepsiCo
PEP
$186B
| $772K | 0.9% |
4,235
-300
| -7% | -$52.4K |
|
18
Schwab US Broad Market ETF
SCHB
$44.2B
| $762K | 0.89% |
47,790
-600
| -1% | -$9.38K |
|
19
Elevance Health
ELV
$92B
| $739K | 0.86% |
1,608
-66
| -4% | -$31.4K |
|
|
SLY
20
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $733K | 0.86% |
8,722
-1,325
| -13% | -$115K |
|
21
ExxonMobil
XOM
$679B
| $709K | 0.83% |
6,464
-272
| -4% | -$30.1K |
|
22
DNP Select Income Fund
DNP
$3.89B
| $674K | 0.79% |
61,200
| – | – |
|
23
Visa
V
$701B
| $669K | 0.78% |
2,967
-301
| -9% | -$67K |
|
24
Pfizer
PFE
$158B
| $655K | 0.77% |
16,063
-2,625
| -14% | -$113K |
|
25
Sherwin-Williams
SHW
$78.8B
| $616K | 0.72% |
2,742
| – | – |
|
Similar funds
VA
JRSI
SFG
TPW
ACM
TOTUOP
XFP
ICVCFVA
Indie Asset Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Indie Asset Partners held 93 positions worth $85.6M, down 6.2% from $91.2M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Indie Asset Partners withdrew a net $4.64M in Q1 2023, closing 8 positions and reducing 46 holdings. Its most notable exit was Schwab US Aggregate Bond ETF, an estimated $552K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 51% a quarter earlier, followed by Miscellaneous and Technology.
Against the trend, Indie Asset Partners opened a new position in SPDR Gold Trust worth $561K.
- Indie Asset Partners's largest Q1 2023 buy was SPDR Gold Trust: 3,063 shares worth $561K.
- Indie Asset Partners added most to Eli Lilly in Q1 2023, an estimated $287K increase.
- Indie Asset Partners's biggest Q1 2023 reduction was Royalty Pharma, cutting an estimated $1.08M.
- Indie Asset Partners fully exited Schwab US Aggregate Bond ETF in Q1 2023, selling an estimated $552K.
- Indie Asset Partners's ten largest holdings make up 65% of its $85.6M portfolio in Q1 2023.
- Indie Asset Partners opened 8 new positions and closed 8 in Q1 2023.
- Indie Asset Partners's portfolio value fell 6.2% quarter-over-quarter to $85.6M.
Based on Indie Asset Partners's 13F filing for Q1 2023, filed 11 May 2023.